| CAS ID: | 174722-31-7 |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Monoclonal antibody |
| Natural Product: | No |
| Other Names: | RITUXAN | MABTHERA RITUXAN | RITUXIMAB | IDEC-102 | MABTHERA | IDEC-C2B8 | RG-105 | R-105 IDEC-102 |
| Analysis: | N/A |
Trial Record 1
| ClinicalTrial ID | NCT01524068 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 2 | Status | Withdrawn |
| First Received | February 1, 2012 | Last Verified | January 5, 2016 |
| Sponsor | University of Pittsburgh | ||
Trial Record 2
| ClinicalTrial ID | NCT01969409 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 2 | Status | Active, not recruiting |
| First Received | October 25, 2013 | Last Verified | February 19, 2019 |
| Sponsor | University of Alabama at Birmingham | ||
Trial Record 3
| ClinicalTrial ID | NCT01266317 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 1,Phase 2 | Status | Completed |
| First Received | December 24, 2010 | Last Verified | March 14, 2018 |
| Sponsor | Michael Donahoe | ||
Trial Record 4
| ClinicalTrial ID | NCT01584388 | Disease | Retroperitoneal fibrosis |
| Phase | Phase 1,Phase 2 | Status | Completed |
| First Received | April 25, 2012 | Last Verified | July 2, 2017 |
| Sponsor | Massachusetts General Hospital | ||
Trial Record 5
| ClinicalTrial ID | NCT02705638 | Disease | Retroperitoneal fibrosis |
| Phase | Phase 1 | Status | Active, not recruiting |
| First Received | March 10, 2016 | Last Verified | February 12, 2019 |
| Sponsor | Mayo Clinic | ||
Trial Record 6
| ClinicalTrial ID | NCT00358878 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | August 1, 2006 | Last Verified | May 26, 2016 |
| Sponsor | Sanofi | ||
Trial Record 7
| ClinicalTrial ID | NCT02376335 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | March 3, 2015 | Last Verified | January 13, 2017 |
| Sponsor | Newcastle-upon-Tyne Hospitals NHS Trust | ||
Trial Record 8
| ClinicalTrial ID | NCT00498368 | Disease | Renal fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | July 10, 2007 | Last Verified | February 1, 2017 |
| Sponsor | Mayo Clinic | ||
Trial Record 9
| ClinicalTrial ID | NCT02990286 | Disease | Pulmonary fibrosis |
| Phase | Phase 3 | Status | Recruiting |
| First Received | December 13, 2016 | Last Verified | May 8, 2017 |
| Sponsor | University Hospital, Tours | ||
Trial Record 10
| ClinicalTrial ID | NCT01862926 | Disease | Pulmonary fibrosis |
| Phase | Phase 2,Phase 3 | Status | Recruiting |
| First Received | May 27, 2013 | Last Verified | June 8, 2017 |
| Sponsor | Royal Brompton & Harefield NHS Foundation Trust | ||
Trial Record 11
| ClinicalTrial ID | NCT01748084 | Disease | Systemic sclerosis |
| Phase | Phase 2,Phase 3 | Status | Completed |
| First Received | December 12, 2012 | Last Verified | March 2, 2018 |
| Sponsor | Assistance Publique - Hôpitaux de Paris | ||
| PubChem: | 56314417 |
| ChEMBL: | CHEMBL1201576 |